L Milazzo

Summary

Affiliation: University of Milan
Country: Italy

Publications

  1. pmc Short communication: impact of hepatitis C viral clearance on CD4+ T-lymphocyte course in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin
    Laura Milazzo
    Department of Clinical Sciences, Section of Infectious Diseases and Immunopathology L Sacco, Universita degli Studi di Milano, L Sacco Hospital, Milan, Italy
    AIDS Res Hum Retroviruses 28:989-93. 2012
  2. doi request reprint Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy
    L Milazzo
    Section of Infectious Diseases and Immunopathology, Department of Clinical Sciences L Sacco, Universita degli Studi di Milano, L Sacco Hospital, Milan, Italy
    Transpl Infect Dis 14:95-8. 2012
  3. ncbi request reprint Early viral kinetics: a novel guide for optimal dosing frequency of pegylated interferon-α-2a in HIV/HCV-coinfected patients
    Laura Milazzo
    Department of Clinical Sciences, Section of Infectious Diseases and Immunopathology L Sacco, Universita degli Studi di Milano, Via GB Grassi 74, Milan, Italy
    Expert Rev Anti Infect Ther 9:859-62. 2011
  4. ncbi request reprint Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population
    Laura Milazzo
    Section of Infectious Diseases and Immunopathology, Department of Clinical Sciences L Sacco, Universita degli Studi di Milano, L Sacco Hospital, Milan, Italy
    Curr HIV Res 9:186-93. 2011
  5. doi request reprint Effect of antioxidants on mitochondrial function in HIV-1-related lipoatrophy: a pilot study
    Laura Milazzo
    Universita degli Studi di Milano, Department of Clinical Sciences, L Sacco Hospital, Section of Infectious Diseases and Immunopathology, Milan, Italy
    AIDS Res Hum Retroviruses 26:1207-14. 2010
  6. doi request reprint Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study
    Laura Milazzo
    Department of Clinical Sciences, University of Milan, L Sacco Hospital, Milan, Italy
    J Antimicrob Chemother 65:735-40. 2010
  7. doi request reprint Telbivudine in the treatment of chronic hepatitis B: experience in HIV type-1-infected patients naive for antiretroviral therapy
    Laura Milazzo
    Department of Clinical Sciences, Infectious Diseases and Immunopathology, University of Milan, Milan, Italy
    Antivir Ther 14:869-72. 2009
  8. doi request reprint Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients
    L Milazzo
    Section of Infectious Diseases and Immunopathology, Department of Clinical Sciences L Sacco, University of Milan, Milan, Italy
    J Viral Hepat 16:479-84. 2009
  9. doi request reprint Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV-coinfected patients
    M Cesari
    Department of Clinical Sciences L Sacco, Section of Infectious Diseases and Immunopathology, University of Milan, Milan, Italy
    HIV Med 10:580-5. 2009
  10. ncbi request reprint Predictability of sustained virological response to pegylated interferon alpha-2b Plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C virus infection
    E Angeli
    II Dept Infectious Diseases, L Sacco Hospital, Via G B Grassi 74, Milan 20157, Italy
    Curr HIV Res 7:447-55. 2009

Detail Information

Publications14

  1. pmc Short communication: impact of hepatitis C viral clearance on CD4+ T-lymphocyte course in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin
    Laura Milazzo
    Department of Clinical Sciences, Section of Infectious Diseases and Immunopathology L Sacco, Universita degli Studi di Milano, L Sacco Hospital, Milan, Italy
    AIDS Res Hum Retroviruses 28:989-93. 2012
    ..The clearance of HCV replication did not affect the CD4(+) changes after Peg-IFN-RBV therapy in coinfected patients on efficient cART. Liver fibrosis and higher BMI were negative determinants of immune recovery...
  2. doi request reprint Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy
    L Milazzo
    Section of Infectious Diseases and Immunopathology, Department of Clinical Sciences L Sacco, Universita degli Studi di Milano, L Sacco Hospital, Milan, Italy
    Transpl Infect Dis 14:95-8. 2012
    ....
  3. ncbi request reprint Early viral kinetics: a novel guide for optimal dosing frequency of pegylated interferon-α-2a in HIV/HCV-coinfected patients
    Laura Milazzo
    Department of Clinical Sciences, Section of Infectious Diseases and Immunopathology L Sacco, Universita degli Studi di Milano, Via GB Grassi 74, Milan, Italy
    Expert Rev Anti Infect Ther 9:859-62. 2011
    ..This promising novel therapeutic approach to improve sustained virologic response in difficult-to-treat populations is discussed in relation to the key findings of the article...
  4. ncbi request reprint Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population
    Laura Milazzo
    Section of Infectious Diseases and Immunopathology, Department of Clinical Sciences L Sacco, Universita degli Studi di Milano, L Sacco Hospital, Milan, Italy
    Curr HIV Res 9:186-93. 2011
    ..Furthermore, hypovitaminosis D was reported in HIV-infected individuals, but its role in liver disease progression in HIV/HCV coinfection is unknown...
  5. doi request reprint Effect of antioxidants on mitochondrial function in HIV-1-related lipoatrophy: a pilot study
    Laura Milazzo
    Universita degli Studi di Milano, Department of Clinical Sciences, L Sacco Hospital, Section of Infectious Diseases and Immunopathology, Milan, Italy
    AIDS Res Hum Retroviruses 26:1207-14. 2010
    ..Our study showed that antioxidant supplementation may have a protective role on mitochondrial function, with limited effects on the reversal of clinical lipodystrophic abnormalities in HIV-1-infected patients...
  6. doi request reprint Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study
    Laura Milazzo
    Department of Clinical Sciences, University of Milan, L Sacco Hospital, Milan, Italy
    J Antimicrob Chemother 65:735-40. 2010
    ..We evaluated in this open-label, randomized controlled study the efficacy of fluvastatin as adjuvant to pegylated-(PEG)-IFN and ribavirin in HIV/HCV genotype 1 co-infected patients...
  7. doi request reprint Telbivudine in the treatment of chronic hepatitis B: experience in HIV type-1-infected patients naive for antiretroviral therapy
    Laura Milazzo
    Department of Clinical Sciences, Infectious Diseases and Immunopathology, University of Milan, Milan, Italy
    Antivir Ther 14:869-72. 2009
    ....
  8. doi request reprint Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients
    L Milazzo
    Section of Infectious Diseases and Immunopathology, Department of Clinical Sciences L Sacco, University of Milan, Milan, Italy
    J Viral Hepat 16:479-84. 2009
    ..CD36 expression on monocytes were not up-regulated by statins as previously reported in vitro. The correlation between HCV infectivity, oxidized-LDL receptor and statins in HCV infection need further evaluation...
  9. doi request reprint Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV-coinfected patients
    M Cesari
    Department of Clinical Sciences L Sacco, Section of Infectious Diseases and Immunopathology, University of Milan, Milan, Italy
    HIV Med 10:580-5. 2009
    ..Conversely, insulin resistance reduces SVR rates. We investigated the influence of baseline glucose and lipid values on the outcome of hepatitis C virus (HCV) treatment in HIV-1 infected subjects...
  10. ncbi request reprint Predictability of sustained virological response to pegylated interferon alpha-2b Plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C virus infection
    E Angeli
    II Dept Infectious Diseases, L Sacco Hospital, Via G B Grassi 74, Milan 20157, Italy
    Curr HIV Res 7:447-55. 2009
    ..The study of viral kinetics requires further investigations in HIV-positive patients to guarantee a cost-effective therapy and to guide individually the duration of treatment. In this setting, TMA might be useful...
  11. doi request reprint AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy
    S Antinori
    Luigi Sacco Department of Clinical Sciences, Section of Infectious Diseases and Immunopathology, University of Milan, Italy
    HIV Med 10:6-11. 2009
    ..Conclusions The AIDS-associated cryptococcosis observed in Western countries in the HAART era has similar clinical and immunological characteristics to that observed in the pre-HAART era, but a significantly better outcome...
  12. ncbi request reprint Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial
    S Rusconi
    Infectious Disease Unit, Luigi Sacco Hospital, University of Milan, Italy
    Antivir Ther 2:39-46. 1997
    ..The degree of phenotypic resistance to both zidovudine and lamivudine correlated with the amino acid changes in RNA and the rapid increase in viral load...
  13. pmc Altered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infection
    L Meroni
    Department of Clinical Sciences Section of Infectious Diseases and Tropical Medicine, L Sacco Hospital, Milan, Italy
    Clin Exp Immunol 147:53-9. 2007
    ..Up-regulation of CD81 mRNA on CD4(+) T cells indicates that down-regulation of CD81 occurs at the post-transcriptional/translational level...
  14. ncbi request reprint Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure
    S Rusconi
    Istituto di Malattie Infettive e Tropicali, Universita di Milano, Ospedale Luigi Sacco, Italy
    Antivir Ther 3:203-7. 1998
    ..Our passaging strategy led to a decrease in lamivudine IC50 values, which were comparable to those prior to lamivudine exposure, and the genotypic restoration of the wild-type sequence at codon 184 of reverse transcriptase...